Phase 3 Trial Assesses Orforglipron for Obesity in Japanese Population | Retatrutide News

A phase 3 trial evaluated the safety and efficacy of oral orforglipron in Japanese participants with obesity. This study contributes to the understandin...
Clinical Trials · November 1, 2026